Treatment outcomes for multidrug- and rifampicin-resistant tuberculosis in Central and West Africa: a systematic review and meta-analysis

•Multidrug-resistant/rifampicin-resistant tuberculosis remains a major threat to global health, mainly in low-income settings.•We found a successful treatment outcome of 74.6% in Central and West Africa.•The World Health Organization reported an average global success rate of 59% in 2018.•Shorter an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of infectious diseases Jg. 124; S. S107 - S116
Hauptverfasser:	Toft, Asbjørn Langeland, Dahl, Victor Næstholt, Sifna, Armando, Ige, Olusoji Mayowa, Schwoebel, Valérie, Souleymane, Mahamadou Bassirou, Piubello, Alberto, Wejse, Christian
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Canada Elsevier Ltd 01.11.2022 Elsevier
Schlagworte:	Africa Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Directly Observed Therapy Drug-resistance Epidemiology Humans Mycobacterium tuberculosis Rifampin - pharmacology Rifampin - therapeutic use Treatment Outcome Tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology Treatment outcome Tuberculosis Drug-resistance Epidemiology Africa
ISSN:	1201-9712, 1878-3511, 1878-3511
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!